RT @canhepc: CanHepC trainee @adelinaartenie on the adequacy of dosage in opioid agonist therapy. Great presentation! https://t.co/4TD2SrCm…
RT @canhepc: CanHepC trainee @adelinaartenie on the adequacy of dosage in opioid agonist therapy. Great presentation! https://t.co/4TD2SrCm…
CanHepC trainee @adelinaartenie on the adequacy of dosage in opioid agonist therapy. Great presentation! https://t.co/4TD2SrCme6 https://t.co/Fl6TSifg04
RT @adelinaartenie: Really happy our work is finally out! OAT is key to #hcv prevention efforts but the benefits of treatment do not extend…
RT @CMAJ: Opioid agonist treatment dosage adequacy, both actual and perceived, influences risk of acquiring #hepatitisC among people who in…
RT @adelinaartenie: Really happy our work is finally out! OAT is key to #hcv prevention efforts but the benefits of treatment do not extend…
Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs https://t.co/bbucuzmaAb #Biobanking
RT @adelinaartenie: Really happy our work is finally out! OAT is key to #hcv prevention efforts but the benefits of treatment do not extend…
RT @adelinaartenie: Really happy our work is finally out! OAT is key to #hcv prevention efforts but the benefits of treatment do not extend…
RT @adelinaartenie: Really happy our work is finally out! OAT is key to #hcv prevention efforts but the benefits of treatment do not extend…
Really happy our work is finally out! OAT is key to #hcv prevention efforts but the benefits of treatment do not extend equally to all. We observed the greatest reduction in HCV risk for patients prescribed higher doses and who also evaluated their tx as a
RT @CMAJ: Opioid agonist treatment dosage adequacy, both actual and perceived, influences risk of acquiring #hepatitisC among people who in…
RT @CMAJ: Opioid agonist treatment dosage adequacy, both actual and perceived, influences risk of acquiring #hepatitisC among people who in…
RT @CMAJ: Opioid agonist treatment dosage adequacy, both actual and perceived, influences risk of acquiring #hepatitisC among people who in…
Opioid agonist treatment dosage adequacy, both actual and perceived, influences risk of acquiring #hepatitisC among people who inject drugs, new research finds. https://t.co/max9SGzapO #HCV https://t.co/XrFWhqEZAb
Our commentary refers to an important observational study today in @CMAJ by Artenee, Bruneau, and colleagues that exploring whether OAT's perception of dosage adequacy is associated with health outcomes (in this case, new infections of Hepatitis C) https: